With Bayer facing investor pressure to resolve thousands of lawsuits over its Roundup weedkiller after being hit with $2 billion in verdicts in recent weeks, all eyes are on a trial wrapping up in Philadelphia. Plaintiffs have won the last …
Investors are demanding around 2.2 billion euros ($2.5 billion) from Bayer as part of a possible class action lawsuit in Germany over the takeover of U.S. seed manufacturer Monsanto, law firm Tilp said on Monday. The law firm said that …
BERLIN – Bayer faces a billion-dollar investor class action lawsuit in Germany over the takeover of U.S. seed manufacturer Monsanto, specialist law firm Tilp Rechtsanwaltsgesellschaft said on Wednesday. Tilp said it was representing more than 250 institutional investors and a …
Bayer lost a third appeal against U.S. court verdicts that awarded damages to customers blaming their cancers on use of its glyphosate-based weedkillers, leaving the German drugs and pesticides group to pin hopes for legal relief on the U.S. Supreme …
A federal judge on Tuesday questioned a $2 billion proposal by Bayer AG that would create a framework for resolving future claims that its Roundup weedkiller causes cancer, casting doubt on the plan a day before a key hearing. Bayer …
Bayer shares fell more 6% on Tuesday after a U.S. judge questioned part of the German company’s proposed settlement to deal with future claims relating to allegations that its widely used weedkiller Roundup caused cancer. Last month Bayer agreed to …
The U.S. Environmental Protection Agency said on Thursday it finished a regulatory review that found glyphosate, the most widely used weed killer in the United States, is not a carcinogen. The conclusion reaffirms the agency’s stance on glyphosate, the key …
